Gedela, S., Noronha, V., Prabhash, K. (2026). Clinical outcomes with low-dose lorlatinib in
                    <i>ALK</i>
                    mutation–positive metastatic lung adenocarcinoma: Experience from a tertiary care center in a developing country.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e20764